Brazil buys large quantity of Ukrainian insulin
. Ukraine's Indar plant for the production of insulin will supply 3.5 million vials of insulin to Brazil until the end of the year. Agreement to this effect was reached by the heads of PJSC Indar (Ukraine) and the Brazilian public pharmaceutical concern Farmanguinhos/Fiocruz.
As UKRINFORM learned from the Indar press service Tuesday, the parties have launched the third stage of practical implementation of the agreement on the supply of insulin to Brazil. "Under the contract, until the end of 2012, Indar will supply to Brazil 3.5 million bottles of genetically engineered human insulin under its own brand name Humodar," the press service says.
In this context, Indar Board Chairman Liubov Vyshnevska stressed that the extension of the contract with Brazil "is a very important step in the development of all domestic pharmaceutical industry." The Latin American market, she says, "without a doubt is one of the most promising for Ukrainian exports."
Brazilian experts, on the other hand, pointed out that the main criterion for the selection of the Ukrainian partner was the quality of drugs. That is why the choice was made in favor of Humodar TM insulins. The Ukrainian insulin has been recently re-registered in Brazil. In the future this will allow Indar going to other Latin American markets.
In addition to the supply of insulin, the Ukrainian company during October-December 2012 will hold a training of the Farmanguinhos/Fiocruz expert team at production facilities in Kyiv. It is also planned to transfer to Brazilian counterparts samples of crude recombinant human insulin and insulin producer strain for further study. Brazil is planning to start the production of insulin by the Ukrainian technology in the future.
The contract for the supply of insulin is implemented as agreed by the presidents of Ukraine and Brazil in October 2011. This is one of the two projects of bilateral economic cooperation. The second strategic area of cooperation is the outer space industry and rocket science.
